238 related articles for article (PubMed ID: 18354225)
21. A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis.
Cordova KN; Willis VC; Haskins K; Holers VM
J Immunol; 2013 Feb; 190(4):1457-65. PubMed ID: 23319740
[TBL] [Abstract][Full Text] [Related]
22. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
[TBL] [Abstract][Full Text] [Related]
23. Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response.
Guichelaar T; ten Brink CB; van Kooten PJ; Berlo SE; Broeren CP; van Eden W; Broere F
J Immunol; 2008 Feb; 180(3):1373-81. PubMed ID: 18209031
[TBL] [Abstract][Full Text] [Related]
24. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
Zhang J; Bárdos T; Mikecz K; Finnegan A; Glant TT
J Immunol; 2001 Apr; 166(8):4981-6. PubMed ID: 11290777
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
26. B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.
Yu S; Dunn R; Kehry MR; Braley-Mullen H
J Immunol; 2008 Jun; 180(11):7706-13. PubMed ID: 18490774
[TBL] [Abstract][Full Text] [Related]
27. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
Hamel KM; Cao Y; Olalekan SA; Finnegan A
Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
[TBL] [Abstract][Full Text] [Related]
28. Depletion of B cells in murine lupus: efficacy and resistance.
Ahuja A; Shupe J; Dunn R; Kashgarian M; Kehry MR; Shlomchik MJ
J Immunol; 2007 Sep; 179(5):3351-61. PubMed ID: 17709552
[TBL] [Abstract][Full Text] [Related]
29. In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells.
Zhang B; Wang Y; Yuan Y; Sun J; Liu L; Huang D; Hu J; Wang M; Li S; Song W; Chen H; Zhou D; Zhang X
Ann Rheum Dis; 2021 Feb; 80(2):176-184. PubMed ID: 32998865
[TBL] [Abstract][Full Text] [Related]
30. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.
Edwards JC; Leandro MJ; Cambridge G
Curr Dir Autoimmun; 2005; 8():175-92. PubMed ID: 15564721
[TBL] [Abstract][Full Text] [Related]
31. B cell-directed therapy in rheumatoid arthritis--clinical experience.
Panayi GS
J Rheumatol Suppl; 2005 Feb; 73():19-24; discussion 29-30. PubMed ID: 15693112
[TBL] [Abstract][Full Text] [Related]
32. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
Hoffmann MH; Tuncel J; Skriner K; Tohidast-Akrad M; Türk B; Pinol-Roma S; Serre G; Schett G; Smolen JS; Holmdahl R; Steiner G
J Immunol; 2007 Dec; 179(11):7568-76. PubMed ID: 18025202
[TBL] [Abstract][Full Text] [Related]
33. Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice.
Boldizsar F; Kis-Toth K; Tarjanyi O; Olasz K; Hegyi A; Mikecz K; Glant TT
Arthritis Rheum; 2010 Oct; 62(10):2984-94. PubMed ID: 20564001
[TBL] [Abstract][Full Text] [Related]
34. An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.
Mikecz K; Glant TT; Markovics A; Rosenthal KS; Kurko J; Carambula RE; Cress S; Steiner HL; Zimmerman DH
Vaccine; 2017 Jul; 35(32):4048-4056. PubMed ID: 28583308
[TBL] [Abstract][Full Text] [Related]
35. Depletion of CD20 B cells fails to inhibit relapsing mouse experimental autoimmune encephalomyelitis.
Sefia E; Pryce G; Meier UC; Giovannoni G; Baker D
Mult Scler Relat Disord; 2017 May; 14():46-50. PubMed ID: 28619431
[TBL] [Abstract][Full Text] [Related]
36. B-cell: a logical target for treatment of rheumatoid arthritis.
Youinou P; Jamin C; Saraux A
Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
[TBL] [Abstract][Full Text] [Related]
37. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J
Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543
[TBL] [Abstract][Full Text] [Related]
38. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
[TBL] [Abstract][Full Text] [Related]
39. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice.
Horikawa M; Minard-Colin V; Matsushita T; Tedder TF
J Clin Invest; 2011 Nov; 121(11):4268-80. PubMed ID: 22019587
[TBL] [Abstract][Full Text] [Related]
40. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.
Misják P; Bősze S; Horváti K; Pásztói M; Pálóczi K; Holub MC; Szakács F; Aradi B; György B; Szabó TG; Nagy G; Glant TT; Mikecz K; Falus A; Buzás EI
Immunol Lett; 2013 Apr; 152(1):25-31. PubMed ID: 23578666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
